Atlas Trials

Ebola

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ebola

RecordFirmDate
A Study in Tanzania of a New Vaccine Against Two Types of Ebola (NCT05301504)University of Oxford2022-03-30
A Study of a New Vaccine Against Two Types of Ebola (NCT05079750)University of Oxford2021-11-11
Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study) (NCT05064956)London School of Hygiene and Tropical Medicine2021-10-06
A Study of 2-dose Vaccine Regimen Using 3 Consecutive Lots of Ad26.ZEBOV and MVA-BN-Filo in Adult Participants (NCT04228783)Janssen Vaccines & Prevention B.V.2020-02-18
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola (NCT03031912)Canadian Immunization Research Network2017-08-01
GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen (NCT02818582)National Institute of Allergy and Infectious Diseases (NIAID)2016-07-01
Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects (NCT02370589)Novavax2015-02-01
A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo (NCT02240875)University of Oxford2014-09-17
Poly-ICLC to Prevent Respiratory Viral Infections A Safety Study (NCT00646152)National Institute of Allergy and Infectious Diseases (NIAID)2008-03-24

Track Ebola automatically

Every clearance here is in the API, with alerts when new ones post.